Form 4 · Filed May 18, 2026, 08:38 PM UTC
SLNO/SOLENO THERAPEUTICS INC
Huang Michael F. — Sr. VP of Clinical Development
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 18, 2026 | D | other | 39,823 | — | — | 0 |
| May 18, 2026 | D | other | 110,000 | — | — | 0 |
| May 18, 2026 | D | other | 13,800 | — | — | 0 |
| May 18, 2026 | D | other | 11,900 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0002019992-26-000003